Matthew B. Murphy - General Counsel at Nautilus Biotechnology, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
General Counsel
Stock Symbol
NAUT on Nasdaq
Industry
Laboratory Analytical Instruments
All Insider Reports
All Insider Reports

Matthew B. Murphy - trading volume in the past year for Nautilus Biotechnology, Inc.

Holdings reported by Matthew B. Murphy for Nautilus Biotechnology, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 74.1K $47.7K $0.64 Sep 4, 2025 Indirect
Common Stock 1.25K $1K $0.80 Sep 4, 2025 Direct
Stock Option (Right to Buy) 160K Mar 3, 2025 Direct Common Stock

Transactions reported by Matthew B. Murphy for Nautilus Biotechnology, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.